Erratum: Integrated molecular dissection of the epidermal growth factor receptor (EGFR) oncogenic pathway to predict response to EGFR-targeted monoclonal antibodies in metastatic colorectal cancer (Targeted Oncology DOI 10.1007/s11523-010-0138-5)